This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/523207-who-approves-sinopharm-covid-vaccine/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| WHO gives emergency approval to China's Sinopharm Covid-19 vaccine, sixth jab to be backed by UN agency | WHO gives emergency approval to China's Sinopharm Covid-19 vaccine, sixth jab to be backed by UN agency |
| (about 1 month later) | |
| The World Health Organization (WHO) has given emergency use authorization to a Covid-19 vaccine manufactured by China's Sinopharm, making it the sixth such inoculation to receive the agency's green light. | The World Health Organization (WHO) has given emergency use authorization to a Covid-19 vaccine manufactured by China's Sinopharm, making it the sixth such inoculation to receive the agency's green light. |
| The approval of the jab, which was developed with the Beijing Institute of Biological Products, is for all adults aged 18 and over with a two-dose regimen. | The approval of the jab, which was developed with the Beijing Institute of Biological Products, is for all adults aged 18 and over with a two-dose regimen. |
| The vaccine demonstrated an overall efficacy against Covid-19 of 78.1% in international phase 3 clinical trials and 78.7% efficacy in preventing hospitalization, according to WHO data. | The vaccine demonstrated an overall efficacy against Covid-19 of 78.1% in international phase 3 clinical trials and 78.7% efficacy in preventing hospitalization, according to WHO data. |
| “This afternoon, WHO gave emergency use listing to Sinopharm Beijing's Covid-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality,” the health agency's Director General Tedros Adhahom Ghebreysus said on Friday. | “This afternoon, WHO gave emergency use listing to Sinopharm Beijing's Covid-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality,” the health agency's Director General Tedros Adhahom Ghebreysus said on Friday. |
| He added that the Sinopharm approval expands the list of jabs that can be bought by the COVAX facility – the initiative designed to boost equitable global vaccine distribution. | He added that the Sinopharm approval expands the list of jabs that can be bought by the COVAX facility – the initiative designed to boost equitable global vaccine distribution. |
| Sinopharm has produced two Covid-19 vaccines in total, with its other jab developed with the Wuhan Institute of Biological Products. This two-dose jab has not yet been approved by the WHO. | Sinopharm has produced two Covid-19 vaccines in total, with its other jab developed with the Wuhan Institute of Biological Products. This two-dose jab has not yet been approved by the WHO. |
| The other vaccines given the green light by the health agency to date are those from Pfizer-BioNTech, Moderna, Oxford-AstraZeneca, the Serum Institute of India, and Johnson & Johnson. | The other vaccines given the green light by the health agency to date are those from Pfizer-BioNTech, Moderna, Oxford-AstraZeneca, the Serum Institute of India, and Johnson & Johnson. |
| While most of the jabs approved by the WHO are either mRNA or viral vector vaccines, Beijing's Sinopharm product is what's known as an ‘inactivated’ inoculation. | While most of the jabs approved by the WHO are either mRNA or viral vector vaccines, Beijing's Sinopharm product is what's known as an ‘inactivated’ inoculation. |
| Vaccines in this category contain a dead part of the virus, which when injected will trigger an immune response in the body to fight infection. | Vaccines in this category contain a dead part of the virus, which when injected will trigger an immune response in the body to fight infection. |
| Sinopharm's vaccine has also been authorized for adults by some 45 countries and jurisdictions globally, while more than 65 million doses have been administered to date. | Sinopharm's vaccine has also been authorized for adults by some 45 countries and jurisdictions globally, while more than 65 million doses have been administered to date. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |